| NCT07583277 | Selective Dorsal Rhizotomy as a Cost Effective and Safe Procedure as a Alternative to Intrathecal Baclofen Pump in Patients With Post Traumatic Spasticity | Assiut University | | - Age ≥ 4 yrs
- Level C1-S5
AIS - All
- NOT have undergone a previous intrathecal baclofen pump administration
| Recruiting soon | 32 | NA | Surgery | Spasticity | - Ashworth and Modified Ashworth Scale (MAS)
- Surface Electromyography (sEMG)
| 6 months | 01 June 2026 | 13 May 2026 | 0 | |
| NCT07583498 | Spasticity in SCI Following Acute Intermittent Hypoxia | Shirley Ryan AbilityLab | | - Age ≥ 18 yrs
- Level C1-C8
AIS C, D- ≥ 6 months
- NOT have a tracheostomy or who utilize mechanical ventilation
| Recruiting | 10 | NA | Drug | Spasticity | - Ashworth and Modified Ashworth Scale (MAS)
| 0 days | 17 March 2026 | 13 May 2026 | 1 | |
| NCT07578532 | The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord Injury | Ankara City Hospital Bilkent | | - Age 18 - 65 yrs
- Level C1-S5
AIS - All
- NOT have a cardiac pacemaker
- NOT have undergone surgical procedure for neurogenic bladder
- have an overactive bladder that has not responded to medication for the last 3 months
| Recruiting | 40 | NA | Technology | Bladder health/function | - Neurogenic Bowel Dysfunction Score (NBD or NBDS)
- Pain Visual Analog Scale (VAS)
- Spinal Cord Independence Measure (SCIM)
- Surface Electromyography (sEMG)
- Urodynamic examination
| 4 weeks | 26 March 2025 | 11 May 2026 | 1 | |
| NCT07562113 | Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery | University of Alabama at Birmingham | | - Age 18 - 89 yrs
- Level C1-S5
AIS A, B, C, D- All
- NOT have implanted medical device (e.g. pacemaker, cochlear implant)
| Recruiting soon | 50 | PHASE1, PHASE2 | Technology | General health | - Blood Pressure and Heart Rate Regulation
| 48 hours | 01 November 2026 | 01 May 2026 | 1 | |
| NCT07588711 | Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have a pacemaker or other implanted electrical device
| Recruiting soon | 32 | NA | Technology | Pain | - Adverse Events (AEs)
- Feasibility
- Neuropathoc Pain Symptom Inventory (NPSI)
- Spinal Cord Injury – Quality of Life (SCI-QOL)
| 30 days | 01 October 2026 | 15 May 2026 | 1 | |
| NCT07596563 | Olfactory Cell Transplantation and Intensive Rehabilitation to Repair Chronic Spinal Cord Injury | Griffith University | | - Age ≥ 18 yrs
- Level C5-T12
AIS A, B, C- ≥ 4 months
- NOT have any contraindications to FES, MRI, X-ray and other study procedures, such as a cardiac pacemaker or epilepsy
| Recruiting soon | 30 | PHASE1 | Biological/cell based | General health | - 6-Minute Walk Test (6MWT)
- Adverse Events (AEs)
- Blood Pressure and Heart Rate Regulation
- Brief Pain Inventory (BPI)
- Depression Anxiety Stress Scale-21 (DASS-21)
- Feasibility
- Functional Independence Measure (FIM)
- International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Magnetic Resonance Imaging (MRI) - conventional/anatomical and quantitative
- Motor Evoked Potentials (MEPs)
- Pain Numeric Rating Scale (NRS)
- Sensory evoked potentials (including mixed and dermatomal, mSSEPs, dSSEPs, contact heat/laser evoked potentials- CHEPS/LEPs)
- Serum Biomarker
- Spinal Cord Independence Measure (SCIM)
- Urodynamic examination
| 48 weeks | 01 December 2026 | 19 May 2026 | 0 | |
